Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
BCCR
Development and Implementation of The Breast Cancer Collaborative Registry (BCCR)
2 other identifiers
observational
4,945
1 country
65
Brief Summary
RATIONALE: Gathering information about patients with breast cancer and their families may help the study of breast cancer in the future. PURPOSE: This clinical trial is gathering information about patients with breast cancer and their families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2006
Longer than P75 for all trials
65 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2006
CompletedFirst Submitted
Initial submission to the registry
April 24, 2008
CompletedFirst Posted
Study publicly available on registry
April 25, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 19, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 19, 2016
CompletedOctober 10, 2023
October 1, 2023
9.9 years
April 24, 2008
October 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Implementation of a web-based Breast Cancer Collaborative Registry at the National Comprehensive Cancer Network (NCCN) centers
Web-based registry
Ongoing
Merger of data collected under the Adult Oncology Data Collection Study and the National Comprehensive Cancer Network Data Coordinating study at UNMC/NMC
Web-based registries.
Ongoing
Standardization of clinical, environmental, socio-demographic, and family history data collected for breast cancer-related research and shared by the Eppley Breast Cancer Research Group collaborators
Web-based registry.
Ongoing
Interventions
Demographic information (like address and birth date), the results of physical exams, blood tests, x-rays and other diagnostic and medical procedures and treatments, as well as medical and surgical history.
Collection of personal information, medical history, diet and lifestyle habits, any past or current environmental exposures and to re-create a family tree for any cancers that have occurred in any family members. In accordance with OPRR guidelines, no identifying information such as name, address, or date of birth will be used for relatives, but the affected status (cancer, age of onset, year of birth, age of death) will be recorded.
Repository
Tissue procurement.
Cancer care.
Eligibility Criteria
1. Adult individuals (male and female) who have a personal diagnosis/history of breast cancer, atypical hyperplasia, ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS) (as stated in the NCCN Breast and/or Ovarian Genetic Assessment Guidelines v.1.2006 (Appendix A) 2. Adult individuals who have characteristics of hereditary breast cancer, as defined in the NCCN Breast and/or Ovarian Genetic Assessment Guidelines v.1.2006 (Appendix A) or who have a breast cancer risk of \> 1.67% over 5 years as estimated by GAIL Model (Appendix C ) 3. Age 19 or greater 4. Able to provide informed consent
You may qualify if:
- Current diagnosis or history of breast cancer
- Atypical hyperplasia
- Ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS) as defined in the National Comprehensive Cancer Network Breast and/or Ovarian Genetic Assessment Guidelines, v.1.2006
- Characteristics of hereditary breast cancer, as defined in the National Comprehensive Cancer Network Breast and/or Ovarian Genetic Assessment Guidelines, v.1.2006 (relatives have been diagnosed with breast and/or ovarian cancer) OR have a breast cancer risk of \> 1.67% over 5 years as estimated by the GAIL Model
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nebraskalead
- National Cancer Institute (NCI)collaborator
Study Sites (65)
Penrose Cancer Center
Colorado Springs, Colorado, 80907, United States
Centura - Porter Adventist Hospital
Denver, Colorado, 80210, United States
Centura - St. Anthony Hospital
Lakewood, Colorado, 80228, United States
Centura - Parker Adventist Hospital
Parker, Colorado, 80138, United States
Centura - St. Mary Corwin Medical Center
Pueblo, Colorado, 81004, United States
Halifax Health Medical Center
Daytona Beach, Florida, 32114, United States
Florida Hospital Memorial Medical Center
Daytona Beach, Florida, 32117, United States
Hlaifax Health Medical Center
Daytona Beach, Florida, 32127, United States
Florida Hospital Deland
DeLand, Florida, 32720, United States
Florida Hospital FISH
Orange City, Florida, 32763, United States
Halifax Health Medical Center
Ormond Beach, Florida, 32174, United States
Florida Hospital Flagler
Palm Coast, Florida, 32164, United States
Rush-Copley Cancer Care Center
Aurora, Illinois, 60504, United States
Trinity Medical Center
Moline, Illinois, 61265, United States
Rush-Copley Healthcare Center
Yorkville, Illinois, 60560, United States
Community Cancer Care
Anderson, Indiana, 46011, United States
Community Clinical Research Center
Anderson, Indiana, 46011, United States
Community Hospital of Anderson and Madison County, Inc
Anderson, Indiana, 46011, United States
Community Health Network
Indianapolis, Indiana, 46219, United States
Community Cancer Center South
Indianapolis, Indiana, 46227, United States
Community Cancer Center North
Indianapolis, Indiana, 46256, United States
Methodist Jennie Edmundson Hospital
Council Bluffs, Iowa, 51503, United States
Genesis Medical Center
Davenport, Iowa, 52804, United States
Iowa Cancer Specialists
Davenport, Iowa, 52804, United States
Mercy Medical Center, North Iowa
Mason City, Iowa, 50401, United States
Abben Cancer Center
Spencer, Iowa, 51301, United States
Covenant Medical Center, Inc
Waterloo, Iowa, 50702, United States
Saint Luke's Cancer Instititue, South
Overland Park, Kansas, 66213, United States
Tulane University
New Orleans, Louisiana, 70112, United States
Central Maine Medical Center, Bennett Breast Care Center
Lewiston, Maine, 04240, United States
Central Maine Medical Center, Cynthia A. Rydhom Cancer Treatment Center
Lewiston, Maine, 04240, United States
Central Maine Medical Center, Hematology Oncology Associates
Lewiston, Maine, 04240, United States
Central Maine Medical Center
Lewiston, Maine, 04240, United States
Maine Research Associates
Lewiston, Maine, 04240, United States
Meritus Center for Clinical Research
Hagerstown, Maryland, 21742, United States
William E Kahlert Regional Cancer Center
Westminster, Maryland, 21157, United States
Holyoke Medical Center
Holyoke, Massachusetts, 01040, United States
Beth Israel Deaconess Hospital
Plymouth, Massachusetts, 02360, United States
Mercy Hospital - Joplin
Joplin, Missouri, 64804, United States
Saint Luke's Cancer Institute - East
Kansas City, Missouri, 64086, United States
Saint Luke's Cancer Institute
Kansas City, Missouri, 64111, United States
Saint Luke's Cancer Institute - Kansas City North
Kansas City, Missouri, 64118, United States
Saint Luke's Cancer Institute - Liberty
Liberty, Missouri, 64068, United States
Heartland Regional Medical Center dba Mosaic Life Care
Saint Joseph, Missouri, 64506, United States
Heartland Regional Medical Center dba Cancer Care, St. Joseph, Mosaic Life Care
Saint Joseph, Missouri, 64507, United States
Mary Lanning Healthcare/Morrison Cancer Center
Hastings, Nebraska, 68901, United States
Good Samaritan Hospital/Cancer Center
Kearney, Nebraska, 68847, United States
Faith Regional Health Services, Carson Cancer Center
Norfolk, Nebraska, 68701, United States
Great Plains Regional Medical Center
North Platte, Nebraska, 69101, United States
UNMC Eppley Cancer Center, University of Nebraska Medical Center
Omaha, Nebraska, 68198-6805, United States
Regional West Health Services
Scottsbluff, Nebraska, 69361, United States
C.R. Wood Cancer Center, Glens Falls Hospital
Glens Falls, New York, 12801, United States
Faxton St. Lukes (St. Elizabeth campus)
Utica, New York, 13501, United States
Faxton St. Luke's Healthcare (Mohawk Valley Health Systems)
Utica, New York, 13502, United States
Faxton St. Luke's Healthcare (St. Luke's Campus)
Utica, New York, 13502, United States
Cape Fear Valley Health System
Fayetteville, North Carolina, 28304, United States
Trinity Hospital Cancer Care Center
Minot, North Dakota, 58701, United States
Avera Medical Group Oncology and Hematology Aberdeen
Aberdeen, South Dakota, 57401, United States
Avera Cancer Institute
Mitchell, South Dakota, 57301, United States
Avera Cancer Center
Sioux Falls, South Dakota, 57105, United States
Rutland Regional Medical Center
Rutland, Vermont, 05701, United States
Wheaton Franciscan Healthcare - Elmbrook Memorial Hospital
Brookfield, Wisconsin, 53045, United States
Wheaton Franciscan Healthcare - Reiman Cancer Care
Franklin, Wisconsin, 53132, United States
Wheaton Franciscan Healthcare - All Saints
Racine, Wisconsin, 53405, United States
Wheaton Franciscan Healthcare - Wauwatosa Cancer Care
Wauwatosa, Wisconsin, 53226, United States
Biospecimen
Tissue, blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth H Cowan, MD, PhD
University of Nebraska
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2008
First Posted
April 25, 2008
Study Start
October 12, 2006
Primary Completion
August 19, 2016
Study Completion
August 19, 2016
Last Updated
October 10, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share